Achieve Life Sciences Inc. (ACHV)

$ACHV 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide. and nearly half a million deaths in the U.S. annually.12 More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke. Achieve's focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline. Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in smoking cessation by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and by reducing the reward and satisfaction associated with smoking.

CEO

Richard Stewart

Exchange

NASDAQ

Website

achievelifesciences.com

$5M

Total Revenue

13

Employees

$55M

Market Capitalization

-1.67

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Riot Blockchain Inc RIOT 709 213 0.71 -95.25 -3.72
Oncocyte Corporation OCX 104 8 2.13 -1.62 -829.52
Achieve Life Sciences Inc. ACHV 55 5 2.30 -1.67 -397.65

Achieve Life Sciences (NASDAQ:ACHV) Releases Earnings Results, Beats Estimates By $0.09 EPS

5d ago, source: Defense World

Achieve Life Sciences (NASDAQ:ACHV – Get Rating) posted its earnings results on Thursday. The biopharmaceutical company ...

Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference

6d ago, source: YAHOO!Finance

Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and ...

Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update

6d ago, source: YAHOO!Finance

PM EDT today, May 12, 2022SEATTLE and VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, ...

Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q1 2022 Results - Earnings Call Transcript

6d ago, source: Seeking Alpha

Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants John Bencich - CEO & Director Cindy Jacobs - ...

ACHIEVE LIFE SCIENCES, INC.

23d ago, source: MarketWatch

(g)Indebtedness consisting of corporate credit cards of Achieve Life Sciences Technologies Inc., an entity organized under the laws of Canada, maintained with US Bank (or such other financial ...

Achieve Life Sciences Inc - Stock Quote ACHV

8d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Achieve Life Sciences Inc - Stock Sustainability SP4P

27d ago, source: Morningstar%2c Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Health Check: How Prudently Does Achieve Life Sciences (NASDAQ:ACHV) Use Debt?

13d ago, source: Yahoo Finance

We note that Achieve Life Sciences, Inc. (NASDAQ:ACHV) does have debt on its balance sheet. But is this debt a concern to ...

Achieve Life Sciences (NASDAQ:ACHV) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS

4d ago, source: Defense World

Achieve Life Sciences (NASDAQ:ACHV – Get Rating) issued its quarterly earnings data on Thursday. The biopharmaceutical ...

ACHIEVE LIFE SCIENCES, INC.

27d ago, source: MarketWatch

of Achieve Life Sciences, Inc. (“Achieve”), a Delaware corporation, or the Company, for use at the Annual Meeting of Stockholders, or the Annual Meeting, to be held on May 31, 2022 ...

Achieve Life Sciences (NASDAQ:ACHV) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

5d ago, source: ETF Daily News

Charles Schwab Investment Management Inc. purchased a new stake in Achieve Life Sciences during the first quarter valued at approximately $79,000. Raymond James & Associates acquired a new position in ...

Achieve Life Sciences Inc.

20d ago, source: Wall Street Journal

1 Day ACHV -0.43% DJIA -1.12% Russell 2K 0.00% Health Care/Life Sciences -0.23% Richard Alistair Balfour Stewart Executive Chairman Renown Pharmaceuticals Pvt Ltd., Achieve Life Sciences, Inc ...

My Portfolio